کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2071736 | 1544582 | 2015 | 11 صفحه PDF | دانلود رایگان |
Widely observed dysregulation of microRNAs (miRNAs) in human cancer has led to substantial speculation regarding possible functions of these short, non-coding RNAs in cancer development and manipulation of miRNA expression to treat cancer. To achieve miRNA loss-of-function, miRNA sponge technology has been developed to use plasmid or viral vectors for intracellular expression of tandemly arrayed, bulged miRNA binding sites complementary to a miRNA target to saturate its ability to regulate natural mRNAs. A strong viral promoter can be used in miRNA sponge vectors to generate high-level expression of the competitive inhibitor transcripts for either transient or long-term inhibition of miRNA function. Taking the advantage of sharing a common seed sequence by members of a miRNA family, this technology is especially useful in knocking down the expression of a family of miRNAs, providing a powerful means for simultaneous inhibition of multiple miRNAs of interest with a single inhibitor. Knockdown of overexpressed oncogenic miRNAs with the technology can be a rational therapeutic strategy for cancer, whereas inhibition of tumor-suppressive miRNAs by the sponges will be useful in deciphering functions of miRNAs in oncogenesis. Herein, we discuss the design of miRNA sponge expression vectors and the use of the vectors to gain better understanding of miRNA's roles in cancer biology and as an alternative tool for anticancer gene therapy.
Using miRNA sponges to achieve the loss-of-function of oncogenic or tumor suppressive miRNAs. A. Interference of miRNA sponges containing miRNA binding sites with the target miRNA's regulation of its natural mRNA targets in a cell. B. Loss-of-function of oncogenic miRNAs can be a rational therapeutic strategy for cancer treatment. Inhibition of tumorsuppressive miRNAs with this miRNA sponge technology will help decipher functions of miRNAs in oncogenesis.Figure optionsDownload high-quality image (183 K)Download as PowerPoint slide
Journal: Advanced Drug Delivery Reviews - Volume 81, January 2015, Pages 117–127